Market Research Future publishes a half cooked research report on the global automated cell culture. Automated Cell Culture Market at a CAGR of ~ 8.5 % Over The Forecast Period 2017-2023
Pune, India -- (SBWIRE) -- 10/12/2017 -- Automated Cell Culture Market: By Application (Drug Development, Stem Cell Research, Cancer Research), By Type (Finite And Infinite Cell Line Cultures), By Consumables (Media, Sera And Reagents), And By End User (Biotech Companies, Research Organizations, Academic Institutes)- Global Forecast Till 2023
Automated cell cultures are grown and maintained using automated protocols instead of manual controls. It minimizes the human efforts and reduces the chances of contaminations & errors during the cell culture development. Additionally, it makes the process of culturing easy and time savior. According to the report published by WHO, 8.8 million people died of various cancer in 2015, which has increased R&D in the drug development for cancer, which, in turn, will generate the demand for automated cell culture. Various factors, such as rising demand for regenerative medicine, growing biopharmaceutical industries and increasing per capita healthcare expenditures boosts the market. However, lack of awareness, uneven distribution of the technology, and high cost may hamper the market.
Market Players Some of the key players profiled in the report are BD., Tecan Trading AG, Sartorius, TAP Biosystems, Cell Culture Company, LLC, Eppendorf AG., Merck KGaA, Hamilton Company., Thermo Fisher Scientific Inc., and OCTANE BIOTECH INC.
Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on "Global Automated Cell Culture Market" Research Report – Forecast till 2023.
Sample Report Available at https://www.marketresearchfuture.com/sample_request/767.
Regional Analysis The Americas dominate the global market on account of high per capita healthcare expenditures, presence of leading players and prevailing developed technologies within the region. Europe holds the second largest market share due to high acceptance of new technologies and high demand for biotechnology. Moreover, rising investments in healthcare services will boost the market growth. Asia Pacific is expected to show the fastest growth owing to the presence of growing economies within the region including India and China, which have developing biotech and medical services sector. Moreover, increasing investments and initiatives taken by the governments along with the rising acceptance of biotech products within the region will boost the market. The Middle East & Africa holds the least market share and the region is expected to account for the same during the assessment period. The Middle East countries such as Saudi Arabia will lead the market. However, African region will experience the least growth due to low per capita income, low R&D investments, lack of technology and acceptance as well as political barriers.
Segmentation The automated cell culture market has been segmented on the basis of application, type, end users. Based on the application, the market has been segmented into drug development, stem cell research, regenerative medicine, cancer research, and others. Based on type, the market has been segmented into finite cell line cultures and infinite cell line cultures. Based on consumables, the market has been segmented into media, sera, reagents, and others. Based on the end users, the market has been segmented into biotech companies, research organizations, academic institutes, and others.
Browse complete report at https://www.marketresearchfuture.com/reports/automated-cell-culture-market-767.
Market Research Future
Hadapsar, Pune - 411028
India +1 646 845 9312